Q: Hi, I bought SPOT at $140 in Feb 2019 and am thinking of selling after its recent run but wondering what you think of it/if I should just ride the momentum. Has it gotten ahead of itself/how "expensive" is it?
Thank you.
    Thank you.
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
 H&R Real Estate Investment Trust (HR.UN $11.15)
                H&R Real Estate Investment Trust (HR.UN $11.15)
    
        
 Dream Industrial Real Estate Investment Trust (DIR.UN $12.03)
                Dream Industrial Real Estate Investment Trust (DIR.UN $12.03)
    
        
 QUALCOMM Incorporated (QCOM $177.26)
                QUALCOMM Incorporated (QCOM $177.26)
    
        
 American Tower Corporation (REIT) (AMT $179.45)
                American Tower Corporation (REIT) (AMT $179.45)
    
        
 Keysight Technologies Inc. (KEYS $175.37)
                Keysight Technologies Inc. (KEYS $175.37)
    
        
 QUALCOMM Incorporated (QCOM $177.26)
                QUALCOMM Incorporated (QCOM $177.26)
    
        
 Skyworks Solutions Inc. (SWKS $79.16)
                Skyworks Solutions Inc. (SWKS $79.16)
    
        
 Xilinx Inc. (XLNX)
                Xilinx Inc. (XLNX)
    
        
 American Tower Corporation (REIT) (AMT $179.45)
                American Tower Corporation (REIT) (AMT $179.45)
    
        
 Baylin Technologies Inc. (BYL $0.31)
                Baylin Technologies Inc. (BYL $0.31)
    
        
 Keysight Technologies Inc. (KEYS $175.37)
                Keysight Technologies Inc. (KEYS $175.37)
    
        
 Nokia Corporation Sponsored American Depositary Shares (NOK $7.13)
                Nokia Corporation Sponsored American Depositary Shares (NOK $7.13)
    
        
 Biogen Inc. (BIIB $149.61)
                Biogen Inc. (BIIB $149.61)
    
        
 Gilead Sciences Inc. (GILD $118.44)
                Gilead Sciences Inc. (GILD $118.44)
    
        
 Regeneron Pharmaceuticals Inc. (REGN $654.04)
                Regeneron Pharmaceuticals Inc. (REGN $654.04)
    
        
 AbbVie Inc. (ABBV $228.20)
                AbbVie Inc. (ABBV $228.20)
    
        
 Veeva Systems Inc. Class A (VEEV $285.03)
                Veeva Systems Inc. Class A (VEEV $285.03)